. Author manuscript; available in PMC: 2018 Jan 1.

Published in final edited form as: Transplantation. 2017 Jan;101(1):150–156. doi: 10.1097/TP.0000000000001087

Table 1.

Patient Characteristics (n=221)

Age, y^* Age ≥18, n (%)	16.9 (13.9-19.4) 89 (39)
Male Gender, n (%)	136 (62)
Race, n (%) White African-American/Biracial Hispanic Other/Unknown	139 (63) 33 (15) 26 (12) 23 (10)
Age at Transplantation, y^*	12 (7.3-15.1)
Time post Transplantation, y^*	3.5 (1.3-7)
Primary Acquired Glomerular Disease, n (%)	51 (23)
First Transplant, n (%)	207 (94)
Living Donors, n (%)	130 (59)
Prior Dialysis, n (%)	145 (66)
History of Rejection, n (%)	57 (26)
Immunosuppression, n (%)
Calcineurin Inhibitors	176 (80)
Steroids	94 (43)
Mycophenolate Mofetil	170 (79)
Overweight/Obese, n (%)	78 (35)
Hemoglobin, g/dL^*	12.2 (11.1-13.4)
Anemia, n (%)	47 (22)
Treated for hypertension, n (%)	153 (68)
LVH^§, n (%)	46 (32)
eGFR, Schwartz/CKD-EPI (ml/min/1.73m²)^*	68 (54-89)
eGFR <60 ml/min/1.73m², n (%)	83 (38)

Data are presented as median (IQR)

^§

142 patients had echo data available for analysis